Close X
Tuesday, November 26, 2024
ADVT 
International

US buys more monkeypox vaccine as global case count grows

Darpan News Desk The Canadian Press, 10 Jun, 2022 01:23 PM
  • US buys more monkeypox vaccine as global case count grows

NEW YORK (AP) — The U.S. government is buying more monkeypox vaccine as a surprising international outbreak continues to grow, health officials said Friday.

As of Friday, the U.S. had identified 45 cases in 15 states and the District of Columbia. More than 1,300 cases have been found in about 30 other countries outside the areas of Africa where the virus is endemic.

Officials say the risk to the American public is low, but they are taking steps to assure people that medical measures are in place to deal with the growing problem .

A two-dose vaccine, Jynneos, is approved for monkeypox in the U.S.

The U.S. government has 72,000 Jynneos doses, and will get 300,000 more doses from its manufacturer, Bavarian Nordic, over the next several weeks, said Dawn O’Connell, who oversees the government’s stockpile of emergency vaccines and treatments.

On Friday, the government announced it had ordered 500,000 more Jynneos doses from Bavarian Nordic to be delivered late this year. The company also is holding other doses owned by the U.S. government, she said.

“We have the vaccines and treatments we need to respond,” said O’Connell, of the U.S. Department of Health and Human Services.

Monkeypox is endemic in parts of Africa , where people have been infected through bites from rodents or small animals. It does not usually spread easily among people.

Last month, cases began emerging in Europe and the United States. Many — but not all — of those who contracted the virus had traveled internationally. Most were men who have sex with men, but health officials stress that anyone can get monkeypox.

The Centers for Disease Control and Prevention said Friday that every U.S. case they had looked at involved very close contact.

Officials have alerted doctors to watch for monkeypox cases and offered vaccinations to people in contact with those who were infected.

So far, over 1,400 vaccine courses and over 110 treatment courses have been sent to affected state and local jurisdictions, officials said.

MORE International ARTICLES

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19

Experts call Trump's rosy virus message misguided

Experts call Trump's rosy virus message misguided
The seven-day rolling average for new U.S. cases has climbed over the past two weeks to almost 42,000 per day. The nation also sees more than 700 COVID-19 deaths each day.

Experts call Trump's rosy virus message misguided

With Trump sick, all eyes on Wednesday's VP debate

With Trump sick, all eyes on Wednesday's VP debate
Questions persist about Donald Trump's health following his COVID-19 diagnosis, as well as the age of 77-year-old challenger Joe Biden.

With Trump sick, all eyes on Wednesday's VP debate